Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design (original ) (raw )Percutaneous closure of patent foramen ovale in cryptogenic embolism
Bindu Kalesan
The New England journal of medicine, 2013
View PDFchevron_right
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline
Elke Hoendermis
BMJ (Clinical research ed.), 2018
View PDFchevron_right
Long-Term Propensity Score-Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism
Peter Juni
Circulation, 2012
View PDFchevron_right
Management of patients with patent foramen ovale and cryptogenic stroke
gian paolo anzola
Catheterization and Cardiovascular Interventions, 2013
View PDFchevron_right
Patent Foramen Ovale and Cryptogenic Stroke: Challenges in Diagnosis and Management
ali yafi
Indonesian Journal of Cardiology
View PDFchevron_right
Patent foramen ovale closure and medical therapy for cryptogenic stroke evidence from randomized
Fortune Journals
View PDFchevron_right
Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited
Cesare Baldi
Journal of Clinical Medicine Research, 2016
View PDFchevron_right
A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events
Robert Sommer
Catheterization and Cardiovascular Interventions, 2013
View PDFchevron_right
Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism Long-Term Risk of Recurrent Thromboembolic Events
Bernhard Meier
2000
View PDFchevron_right
Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia
Alessandro Giardini
American Journal of Cardiology, 2004
View PDFchevron_right
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale
Laura Vaskelyte
European Heart Journal, 2013
View PDFchevron_right
Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale
Andrea Berghold
International Journal of Cardiology, 2005
View PDFchevron_right
Prevention of recurrent cryptogenic stroke with percutaneous closure of patent foramen ovale; one year follow-up study with magnetic resonance imaging and Holter monitoring
Giray Kabakcı
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2015
View PDFchevron_right
Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke
Yeong-bae Lee
Journal of interventional cardiology, 2017
View PDFchevron_right
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials
ludmilla mantione
International journal of cardiology, 2018
View PDFchevron_right
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Pil hyung Lee
Journal of the American College of Cardiology, 2018
View PDFchevron_right
Propensity Score–Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale
Valeria De Giuli
Circulation: Cardiovascular Interventions, 2016
View PDFchevron_right
Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
Catherine Lambert
Journal of Interventional Cardiology
View PDFchevron_right
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke
Bernhard Meier
Journal of the American …, 2004
View PDFchevron_right
Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials
mahek shah
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018
View PDFchevron_right
Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack
Guy Reeder , Donald Hagler
JACC: Cardiovascular Interventions, 2009
View PDFchevron_right
732 Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devices
Alain Delabays
European Heart Journal, 2003
View PDFchevron_right
Amplatzer PFO Occluder Device may Prevent Recurrent Stroke in Patients with Patent Foramen Ovale and Cryptogenic Stroke: A Meta-Analysis of Randomised Trials
Leena Jalota
Heart, Lung and Circulation, 2014
View PDFchevron_right
Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis
Claudia Cagnetti
Cerebrovascular Diseases, 2018
View PDFchevron_right
Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies
Marilena Di Salvo
EuroIntervention, 2014
View PDFchevron_right
Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?
Adrià Arboix
Journal of Geriatric Cardiology : JGC, 2021
View PDFchevron_right